Partners and patent attorneys Kate Hickinson and Julia Gwilt discuss how the UPC might work in practice, including the pros and cons of using this new court for infringement and invalidity actions.
Read more In this episode, Appleyard Lees partners, patent attorneys, and experienced opposition specialists, Bobby Smithson and Jennifer Delaney, give their outlook on patent oppositions and appeals at the EPO in 2022.
Read more In this episode, Appleyard Lees partners and solicitors Bill Lister and Chris Hoole discuss the benefits of mediation vs. court proceedings, and how mediation in intellectual property cases can differ to non-intellectual property cases.
Read more In this episode, patent attorneys, partner Kate Hickinson, and senior associate Chris Mason discuss the implications of the UP and UPC.
Read more partner David Walsh, and senior associates Chris Mason and Paul Beynon discuss key insights from the report, and the complexities of analysing patent data.
Read more In this episode of the podcast, we are joined by trade mark attorney Cherry Shin and trainee patent attorney Jonathan Foster to discuss careers in IP.
Read more In this episode, Appleyard Lees solicitors, partner Bill Lister, and Chris Thomas, discuss when a case should be taken to the IPEC, the mechanisms for doing so, and what proceedings may look like once a case reaches the IPEC.
Read more We discuss the advantages and disadvantages of new working practices, and changes to the patent filing process resulting from lock-downs, and the pandemic, more generally.
Read more In 2017, the UK Supreme Court’s judgement of Actavis v Eli Lilly created significant change to the way patent infringement is assessed in the UK by introducing a formal doctrine of equivalents.
Read more As the Tokyo 2020/21 Olympics approach, British wheelchair racing athlete and Paralympic gold medallist Hannah Cockroft discusses her preparation for the games, and the drivers behind innovation in her sport.
Read more In this episode, patent attorneys and Appleyard Lees partners Barbara Fleck, Julia Gwilt and Howard Read, discuss the difficulties of obtaining a patent involving both biotech and software, and the importance of a multidisciplinary team of patent attorneys.
Read more
